Viking Therapeutics (NASDAQ:VKTX) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Viking Therapeutics beat estimated earnings by 8.7%, reporting an EPS of $-0.21 versus an estimate of $-0.23.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 0.31% increase in the share price the next day.
To track all earnings releases for Viking Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
